NCBI PubMed Centralopen access
Prebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 258260
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.